Cargando…

Stem cell-based therapy for pulmonary fibrosis

Pulmonary fibrosis (PF) is a chronic and relentlessly progressive interstitial lung disease in which the accumulation of fibroblasts and extracellular matrix (ECM) induces the destruction of normal alveolar structures, ultimately leading to respiratory failure. Patients with advanced PF are unable t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Wenzhao, Zeng, Yiming, Wang, Dachun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530416/ https://www.ncbi.nlm.nih.gov/pubmed/36195893 http://dx.doi.org/10.1186/s13287-022-03181-8

Ejemplares similares

Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
por: Li, Zhongwen, et al.
Publicado: (2020)

Pulmonary fibrosis: Is stem cell therapy the way forward?
por: Ikrama, Muhammad, et al.
Publicado: (2023)

Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
por: Chuang, Hong-Meng, et al.
Publicado: (2018)

Mesenchymal stem cells in idiopathic pulmonary fibrosis
por: Li, Xiaohong, et al.
Publicado: (2017)

Clinical potentials of human pluripotent stem cells in lung diseases
por: Quan, Yuan, et al.
Publicado: (2014)

Cell Therapy in Idiopathic Pulmonary Fibrosis†
por: Serrano-Mollar, Anna
Publicado: (2018)

Epigenetic Regulation of Fibroblasts and Crosstalk between Cardiomyocytes and Non-Myocyte Cells in Cardiac Fibrosis
por: Chu, Liangyu, et al.
Publicado: (2023)

Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Mesenchymal Stem Cells in Radiation-Induced Pulmonary Fibrosis: Future Prospects
por: Chen, Yusha, et al.
Publicado: (2022)

Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
por: Kletukhina, Sevindzh, et al.
Publicado: (2022)

Induced pluripotent stem cell-based therapies for organ fibrosis
por: Cheng, Wei, et al.
Publicado: (2023)

Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice
por: Han, Meng-Meng, et al.
Publicado: (2023)

Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis
por: Egea-Zorrilla, Alejandro, et al.
Publicado: (2022)

Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis
por: Chuang, Hong-Meng, et al.
Publicado: (2021)

Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
por: Saleh, Mahshid, et al.
Publicado: (2022)

The therapy of idiopathic pulmonary fibrosis: what is next?
por: Somogyi, Vivien, et al.
Publicado: (2019)

Advancements in adipose-derived stem cell therapy for skin fibrosis
por: Liu, Yu-Xin, et al.
Publicado: (2023)

Therapeutic Potential of Exosomes in Pulmonary Fibrosis
por: Xie, Linshen, et al.
Publicado: (2020)

Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
por: Li, Deng-Yuan, et al.
Publicado: (2021)

Current and novel drug therapies for idiopathic pulmonary fibrosis
por: Adamali, Huzaifa I, et al.
Publicado: (2012)

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
por: Maher, Toby M., et al.
Publicado: (2019)

Advances in stem cell therapy for peritoneal fibrosis: from mechanisms to therapeutics
por: Huang, Weiyan, et al.
Publicado: (2023)

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
por: Yang, Shengnan, et al.
Publicado: (2021)

Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis
por: Hong, Xiaojing, et al.
Publicado: (2022)

Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis
por: Zhao, Xiansheng, et al.
Publicado: (2023)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery
por: Sang, Lu, et al.
Publicado: (2022)

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
por: Margaritopoulos, George A, et al.
Publicado: (2016)

Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020)

Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies
por: Wiśniewska, Joanna, et al.
Publicado: (2021)

Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
por: Nazarie (Ignat), Simona-Rebeca, et al.
Publicado: (2021)

The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies
por: Yue, Yue-Liang, et al.
Publicado: (2022)

The Therapy of Pulmonary Fibrosis in Paracoccidioidomycosis: What Are the New Experimental Approaches?
por: González, Ángel
Publicado: (2020)

Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis
por: Kou, Leiya, et al.
Publicado: (2022)

Stem cell therapy in pulmonary hypertension: current practice and future opportunities
por: Zheng, Ruixuan, et al.
Publicado: (2023)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Stem Cell and Exosome Therapy in Pulmonary Hypertension
por: Oh, Seyeon, et al.
Publicado: (2022)

Human pluripotent stem cell-derived macrophages and macrophage-derived exosomes: therapeutic potential in pulmonary fibrosis
por: Rasaei, Roya, et al.
Publicado: (2022)

Mesenchyme Stem Cell-Derived Conditioned Medium as a Potential Therapeutic Tool in Idiopathic Pulmonary Fibrosis
por: Kolios, George, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_43vgicmhmtsiqeq2earjq3u0r4